TAFFA N TMUSNIWIN TUSNANIN

Summary of NACI statement of May 24, 2024: Interim guidance on the use of Imvamune® in the context of a routine immunization program

National Advisory Committee on ImmunizationAselkim2024Asuffeɣ unṣib

Agzul n yisemli ASEM

Official National Advisory Committee on Immunization document (2024) on “Summary of NACI statement of May 24, 2024: Interim guidance on the use of Imvamune® in the context of a routine immunization program”. Valid as of May 24, 2024: Summary of the National Advisory Committee on Immunization's interim guidance on the use of Imvamune in the context of a routine immunization program.

Agzul-a ad k-yefk tallalt deg unadi ɣef uttaft. I wellihen klinik, ẓer yal tikkelt lqem unṣib amiran akked uzemz n uleqqem-is.

Isemli unṣib